Navneet Ammal Kaidery Selected Research

Synucleins

9/2022

Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Navneet Ammal Kaidery Research Topics

Disease

2	Parkinson Disease (Parkinson's Disease) 12/2016 - 01/2013
2	Inflammation (Inflammations) 07/2014 - 01/2013
1	Friedreich Ataxia (Friedreich's Ataxia) 11/2023
1	Multiple Sclerosis 11/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2022
1	Neuroinflammatory Diseases 09/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2014
1	Tauopathies 07/2014

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2016 - 01/2013
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 12/2016 - 01/2013
2	Neuroprotective AgentsIBA 12/2016 - 07/2014
1	Dimethyl FumarateIBA 11/2023
1	Alkylating AgentsIBA 11/2023
1	CalciumIBA 09/2022
1	SynucleinsIBA 09/2022
1	CatecholsIBA 12/2016
1	FlavonoidsIBA 12/2016
1	NF-E2-Related Factor 2IBA 07/2014
1	AntioxidantsIBA 07/2014
1	tau Proteins (tau Protein)IBA 07/2014
1	TriterpenesIBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013

Therapy/Procedure

1	Oral Administration 01/2013